Mersana Therapeutics
MRSN
#9269
Rank
C$0.20 B
Marketcap
C$41.19
Share price
0.00%
Change (1 day)
137.07%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -C$98.54 Million

According to Mersana Therapeutics's latest financial reports the company's current earnings are C$33.18 Million. In 2024 the company made an earning of -C$97.41 Million, an increase over its 2023 earnings that were of -C$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$98.54 Million1.16%
2024 -C$97.41 Million-59.94%
2023 -C$0.25 Billion-15.94%
2022 -C$0.29 Billion20.08%
2021 -C$0.25 Billion93.16%
2020 -C$0.13 Billion212.12%
2019 -C$39.96 Million-56.1%
2018 -C$91.02 Million66.02%
2017 -C$54.83 Million182.53%
2016 -C$19.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion 104.06%๐Ÿ‡บ๐Ÿ‡ธ USA